The model consists on a system of linear partial differential equations describing the size-density of each type of cells. That corresponds to chemotherapeutic treatment on a given time sequence intervals such that, we continuously apply D 0 at a first interval and next we apply D 1 at a second interval, and so forth. We obtain a stable size-distribution theorem for this case.
Introduction
Our aim in this paper is to describe a stable size-distribution theorem for a mathematical model developed to study the cellular resistance in tumor cell populations during alternated chemotherapeutic treatment with two non-cross resistant antiblastic drugs, D 0 and D 1 .
We have considered the size-structure to describe the cellular resistance problem in tumor cell populations because antiblastic drugs are phase-specific, which means that they only act on a determined sensitivity phase of the cells.
It is also incorporated in the model the concept of spontaneous genetic mutation from sensitivity to resistance independent from the selection agent as previously demonstrated in the classical observations of Luria and Delbruck.
In a previous work [15] , we have extended the result of stable size-distribution for a size-structured mathematical model for the growth of a cell population reproducing by binary fission into two exactly equal parts given in [8, Corollary 7.3] . We have considered an extension of that model for a tumor cell population in which two distinct subpopulations is considered: sensitive and resistant. We have shown the existence of stable size-distribution for each tumor cell subpopulation in two cases of only one drug treatment on sensitive cells: (a) a non-stop treatment, and (b) an instantaneous drug action on prescribed times. = −(µ(x) + b(x))r (t, x) + 4b(2x)r(t, 2x) + 4αb(2x)s(t, 2x)
where t denotes the time, x denotes the size of an individual cell, s = s(t, x) denotes the cell size density of sensitive cells at time t, r = r(t, x) denotes the cell size density of resistant cells at time t, α is the constant mutation rate from sensitive into resistant tumor cells and, g(x) is the size-specific individual growth rate; µ(x) is the size-specific per capita death rate, µ F is the drug-kill rate for sensitive cells per capita per unit of time and, b(x) is the size-specific probability of fission per unit of time.
The last term of each equation contains the factor 4 = 2 × 2 due to the fact that a cell divides into 2 parts and the second factor 2 is due to the fact that the size of daughters cells at (x, x + dx) comes from the size of mothers cells at (2x, 2x + 2dx). Added to this, considerations at the level of the population individual cells lead to an evolution problem that generates a strongly-continuous semigroup.
The asymptotic behavior of this semigroup heavily depends on the functional relationship between the cell growth and its size x described by the size-dependent individual growth rate g. In supposing g(2x) < 2g(x) for all relevant x, i. e., the time that a cell needs to grow from size x to size 2x increases with their size x, a stable size-distribution theorem for this problem is given in [15, Theorem 3] :
There exist a Malthusian parameter λ 1 , a stable size-distribution s λ1 (x) for sensitive cells, and a Malthusian parameter λ 2 which has a correspondent stable sizedistribution, r λ2 (x), for resistant cells, such that, as t → ∞,
where λ 1 < λ 2 , C 1 only depends on the first coordinated function of the initial condition φ and C 2 only depends on φ.
The model analyzed in this paper is an extension of the above model. It is formulated as the time-dependent evolution problem (2.6) below, arising from Eq. (2.1) to Eq. (2.4). In Corollary 3.1 we will state the correspondent result of stable sizedistribution.
Roughly its statement is the following. There exist real parameters λ
and, for sufficiently large T , there exist non-negative bounded linear operatorsŝ =ŝ(T ; ·),r 1 =r 1 (T ; ·), r 2 =r 2 (T ; ·) andr d =r d (T ; ·) such that, for all initial condition φ, as n → ∞,
where T > 0 is the duration time for each drug; s(t, φ) is the size-density for cells that are sensitive to both D 0 and D 1 drugs at time t; r 1 (t, φ) is the size-density for cells that are resistant to D 0 at time t; r 2 (t, φ) is the size-density for cells that are resistant to D 1 at time t; r d (t, φ) is the size-density for cells that are resistant to both D 0 and D 1 at time t.
In this case, a stable size-distribution becomes a uniform limit of projections that depends on a convenient choice of the drug duration time T > 0.
As a consequence, each subpopulation has a stable size distribution in the following sense: for all sufficiently large n, the ratio of the number of cells of any subpopulation of tumor cells in a given size-interval by the total number of cells of this subpopulation is time independent.
The Model and Its Interpretation
We consider four different types of tumor cells: The cells grow, die and reproduce by binary fission into two identical daughters. Any r d -cell produces two identical r d -cells, under division. An s-cell can produce two identical s-cells, two identical r 1 -cells or two identical r 2 -cells, under division.
Any r 1 -cell can produce two identical r 1 -cells or two identical r d -cells, under division, and, an r 2 -cell can produce two identical r 2 -cells or two identical r d -cells, under division. It is assumed that any cell of the population is characterized and distinguished from each other by an appropriate physically conserved quantity denoted by x, called the size of a cell of the population. We can interpret the size of a cell as its volume or mass. The proposed size-structured model for the evolution of the tumor cells of the population is described by a nonautonomous linear system, given by following equations (2.1) to (2.4):
where s(t, x) denotes the size-dependent density of s-cells at time t;
Equation for resistance to D 0 and sensitivity to D 1 :
where r 1 (t, x) denotes the size-dependent density of r 1 -cells at time t;
Equation for resistance to D 1 and sensitivity to D 0 :
where r 2 (t, x) denotes the size-dependent density of r 2 -cells at time t;
Equation for resistance to D 0 and
where r d (t, x) denotes the size-dependent density of r d -cells at time t.
The coefficients α 1 , α 2 , g, b, µ, µ D0 , µ D1 are such that: α 1 is the mutation rate constant for s-cells into r 1 -cells and for r 2 -cells into r d -cells; α 2 is the mutation rate constant for s-cells into r 2 -cells and for r 1 -cells into r d -cells; g is the individual size growth rate per unit of time,
b is the probability of division per capita per unit of time; µ is the death rate per capita per unit of time; µ Di (i = 0, 1) is the D i -drug-kill rate time dependent per capita per unit of time, given for all x ∈ Ω by
where µ i is the D i -drug-kill rate per capita per unit of time.
In order to state the evolution problem, we consider:
1. The size x of the cells is normalized with x ≤ x max = 1. We arrive at the following evolution problem
We recall that N α1,α2 (x)u(t, 2x) ≡ 0 (x ∈ Ω 1 ).
Abstract Evolution Problem
Now, we intend to study the solutions of the problem (2.6) considering its timedependent evolution. As we can see, the solution operator of problem (2.6) does not consist on a semigroup of operators. In fact, it is a periodic evolution operator.
In order to simplify the notation we will denote Ω = a 2 , 1 , Ω 0 = a 2 , 1 2 and
We make some technical assumptions: Let F i and F i (i = 0, 1) be defined on Ω by:
and
We have E(x) is the probability of a size a 2 cell to reach the size x without dying or being divided;
is the probability of a size a 2 cell to reach the size x without being killed by D i drug ;
By applying a transformation of dependent variables defined by means of the above functions to the problem (2.6) we have the abstract Cauchy problem (A.1) in the Appendix A.
After that we consider the semigroups {e tAi } t≥0 for i = 0, 1 on a Banach cartesian product space X 4 of continuous functions, generated by the unbounded linear operator A i that correspond to the case of non-stop treatment with the drug D i .
Then from the fact that these semigroups do not commute, we define the weak solution of the abstract evolution problem (A.1) corresponding to (2.6) by composing in a sequence the semigroup {e tA0 } on J 0 then the semigroup {e tA1 } on J 1 and so on.
We give more details about the above considerations in the Appendix A.
implies the compacity in the semigroup e tAi (i = 0, 1) and the analysis of their asymptotic behavior as t → ∞ becomes easier. The same conclusion follows in the case of the biologically unrealistic assumption g(2x) > 2g(x) for x ∈ Ω 0 and the compacity is lost in case of g(2x) = 2g(x) for x ∈ Ω 0 . See [1, Example 4].
Asymptotic Behavior of the Solutions
In the first half of this section we describe the asymptotic behavior for large time of e tA0 and e tA1 in Theorems 3.1 and 3.2, respectively. These are stable sizedistribution theorems that respectively correspond to a chemotherapeutical treatment with a time continuous D 0 action on s-cells and r 1 -cells and, time continuous D 1 action on s-cells and r 1 -cells alternately for a same period of time T . After that, by combining these results, we obtain the asymptotic behavior for large n of (e T A1 e T A0 ) n in Corollary 3.1 for T > 0. From that we deduce a stable sizedistribution theorem for problem (2.6).
Notation. Let we represent any φ ∈ X 4 by a column consisting of four coordinate functions φ 1 , φ 2 , φ 3 and φ 4 belonging to the space X. Following columns are associated with a such φ:
Next developments are based on the assumption
and also on the following (B) a ≥ 1/2 and the functions µ 0 ≥ 0, µ 1 ≥ 0 are continuous, not identical to zero
on Ω = a 2 , 1 .
Cases of Treatment with Only One Drug
If the mutation rates satisfies the inequalities
the asymptotic behavior of the semigroup e tA0 , is given by:
, for all x ∈ Ω 0 . There exist real numbers λ and R dλ4 such that for any φ ∈ X 4 , there exist real constants C
and C 0 (φ) so that for any t ≥ 0 we can write
where for the z i (i = 1, . . . , 4) we have:
It results that there exists a stable size-distribution for each cell subpopulation in the tumor cell population under a non-stop treatment with D 0 . Next, we have a similar result of existence of a stable size-distribution for each cell subpopulation in the tumor cell population under a non-stop treatment with
the asymptotic behavior of the semigroup e tA1 is given by the following theorem. and R dλ4 such that for any given φ ∈ X 4 there exist real constants C
(1)
1 (φ (3) ), C 1 (φ) so that for any t ≥ 0 we can write We combine the results of both theorems above by considering that the mutation rates are equals, that is to say, satisfies the relations 0 < α 2 = α 1 = α < 1/2 to give the asymptotic behavior of e T A1 e T A0 n , as n tends to infinity.
Corollary 3.1. Suppose g(2x) < 2g(x), for all x ∈ Ω 0 . For a convenient choice of T > 0, there exist non-negative bounded linear operators S = S(T, ·),
Proof. The sketch of the proof of this result is given in Appendix C. 3. Theorem 3.1 gives the stable size-distribution for the case µ 0 ≡ µ 1 ≡ 0 which corresponds to the situation where there is no treatment.
Conclusion
In the case of prolonged treatment we found that each cell subpopulation considered has an intrinsic Malthusian parameter and an intrinsic stable size-distribution. In this direction, Corollary 3.1 essentially explains the fact that for appropriate choice of T and for large n each cell subpopulation has their own stable size distribution: "for all n sufficiently large, the ratio of the size distribution of any subpopulation of tumor cells in a given size-interval, by the total subpopulation, is constant, independent of the time".
In this work as in the previous one [15] , we did need a different kind of extension of the stable size-distribution notion than the one given in [1, 8, 21] . They only refer to a population of individuals of the same species. Notice that if one applies directly the results found in the literature, the asymptotic behavior of the sensitive cell subpopulations is completely lost.
Toxicity problems in human chemotherapeutic treatments lead us to think that these theoretical results may have some experimental relevance.
Appendix A. Abstract Evolution Problem Transformation of Variables
Let H 0 and H 1 denote the matrix operators which corresponds respectively to the following formal transformations of dependent variables
with g , F i and F i (i = 0, 1) and E defined respectively by (2.5), (2.7) and (2.8).
Substituting in (2.6) the formal transformation
we have the following transformed problem:
where
Abstract Cauchy Problem
In order to get to the solution of (A.1), we consider for i = 0, 1 the unbounded linear operators A i on X 4 , where X = {φ ∈ C(Ω) : φ(a/2) = 0} with the sup-norm, defined by
and lim x↑
α1,α2 (x)U (2x)] exist and are equal ,
) . One can demonstrate, using arguments similar to those given in [8] , the following result.
Theorem A.1. A i (i = 0, 1) is closed densely defined linear operator on X 4 which generates a linear C 0 -semigroups {e tAi } t≥0 on X 4 .
If g(2x) < 2g(x) for x ∈ Ω 0 , then e tAi is a compact operator for t ≥ G(1).
The solution of (A.1) is given by composition of the solution operators {e tA1 } t≥0 and {e tA0 } t≥0 . Results in Theorem A.1 have correspondents in the initial problem (2.6), i. e., weak solutions of problem (2.6) are given by a sequence of composition of the following semigroups
where, the transformation H i (i = 0, 1) is an isomorphism from Banach space X 4 0 onto X 4 with X 0 = {φ ∈ X : φ/E is bounded } and φ 0 = φ/E ∞ .
Appendix B. Spectral Properties of A i (and e tA )(i = 0, 1)
In this section, we will follow the results contained in [8] and [20] . We also refer the reader to [16, 11] .
The Spectrum of A i (i = 0, 1), Case a ≥ 1 2
Suppose a ≥ 1 2 (i.e., the maximal size of a daughter cell is less than the minimal size of a mother cell). For a detailed study of the general case, see [12, Chapter II] . We make use of the above condition to study U solutions of the equation λU − A i U = f for λ ∈ C and f ∈ X 4 . By doing so, we conclude that x ∈ Ω 0 implies in 2x ∈ Ω 1 and then we first integrate on Ω 1 and on Ω 0 afterwards. Explicitly we have:
In Ω 1 ,
In Ω 0 ,
We also notice that
, (i = 0, 1).
The continuity for x = 1 2 gives the following condition from equations (B.1) and
where we use the notation for i = 0, 1 
(λ)) = 0 then, by solving Eq. (B.3) with f ≡ 0, we can find non trivial eigenfunctions for A i . So λ ∈ σ(A i ).
and λ 4 denote the real eigenvalues of A i . We recall that they satisfy:
and π(λ 4 ) = 1 ,
and π(λ 4 ) = 1 .
Localization of the Eigenvalue for
In this section we suppose each function µ i (i = 0, 1) to be continuous and non identical to zero on Ω. This technical condition is sufficient, for instance, to prove Lemma B.1 below. The analyticity and monotonicity, of π(λ) and π i (λ) when restricted to real λ, imply the following results in this section which extend their correspondent results in [8, Sec. 6] and [20, Sec. 3.4] .
Eigenvalues of A 0 Suppose 0 < α 2 ≤ α 1 < 1 2 . Then, we have:
Eigenvalues of A 1 Suppose 0 < α 1 ≤ α 2 < 1 2 . Then, we have:
In particular we have the following corollary. 
We have a direct sum decomposition
with spectral projection P i :
where the first three components of U λ4 are equal to zero and its fourth component is
P i is the residue at λ = λ 4 in the Laurent development for the resolvent operator (λId − A i ) −1 . Functions C i (φ) are not the same for i = 0, 1.
Remark. e tAi (i = 0, 1) is eventually compact C 0 -semigroup.
Then, for all t ≥ 0,
tAi and e tAi P i φ = e tλ4 P i φ. (c) There exist real numbers K i ≥ 1 and ε i > 0 such that, for all t ≥ 0,
i ) represents for i = 0 and j = 1, 3, or i = 1 and j = 1, 2, 3 the principal order j square sub-matrix operator of A i (resp. e tAi ) acting on X j . In cases i = 0 and j = 2, A
0 ( resp. e t A
0 ) represents the principal order 3 square sub-matrix operator of A 0 ( resp. e tA0 ) having zero entries in their second row and second column as well as, acting on Z = X × {0} × X.
There exist direct sum decompositions for i = 0, 1
i ) (j = 2, if i = 0) denotes a spectral projection. For i = 0, j = 2, we have
In all of the above-mentioned cases, we have that e . We have also π 0 (λ 
We remark that the functions P 0 , P 1 : X 4 → R · {U λ4 } are not the same because in general C 0 (φ) = C 1 (φ).
Given φ ∈ X 4 , we can write
(e 2(n−(j−1))λ4T P 0 + e (2(n−(j−1))−1)λ4T
where we are using the notation: δ 1 := e T A1 (Id − P 1 ) and δ 0 := e T A0 (Id − P 0 ). Taking into account (B.8) we have from (C.1)
1 (Id − P
1 ) δ
We observe by direct calculation that the following hold
• (P 
0 ψ)
These relations imply
We can also deduce the following
It follows from (B.11) and (B.12) the inequalities:
On other side, we can also use for e T A 
and from that
1 e T A
(1) 0 0 0
The operators A i (1−α) (i = 0, 1) and
and lim
The following formula holds Finally, from (C.3), (C.5) (C.6) and (C.8) by taking into account the condition T > 1 ε ln K, i. e., Ke −T ε < 1, the proof of the Corollary 3.1 is completed.
Evolution Problem (2.6)
Mathematically, the existence of stable size-distribution in the evolution problem (2.6) is given by the long time behavior of e T A1 e T A0 n φ = (H 
